Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma

NCT06146127 is registered in ClinicalTrials.gov with Inserm U955 as lead sponsor.

NCT NCT06146127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06146127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
Lead sponsor
Inserm U955
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2001
Completion date
January 30, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer